FDA and FTC Continue to Warn CBD Companies about Unlawful Marketing Claims

Last week, the United States Food and Drug Administration (FDA), in conjunction with the Federal Trade Commission (FTC), issued a warning letter to Rooted Apothecary, LLC in Florida for unlawfully marketing products containing cannabidiol (CBD). The warning letter specifically addresses unsubstantiated claims that the company’s products treat teething pain, ear aches in infants, autism, attention deficit disorders, and Parkinson’s and Alzheimer’s disease. Despite the FDA’s promises to explore potential pathways for the lawful marketing of various CBD products, it has yet to publish any specific…
Continue reading...

Mile High CBD?

It’s not quite what you think, although the concept is somewhat the same — a breakthrough in TSA policy will now allow some cannabidiol (CBD oil) and medications on planes. In April 2019, the Life Science Matters blog wrote about the drug Epidiolex paving the way towards changes in policy and we are now seeing the first tangible result. The Transportation Security Administration modified its cannabis policy to allow flight passengers to bring some forms of CBD oil and FDA approved marijuana based drugs on…
Continue reading...

Medical Cannabis and the Potential for Criminal Charges

This past Monday, February 4, 2019, a medical cannabis patient in Utah plead guilty to a Class B misdemeanor for possession of a controlled substance. The patient had a quantity of CBD oil in his trunk. He used that oil as medicine to treat epilepsy. There are many oils which are good for your health, which includes CBD oil. However, the patient purchased the oil in Oregon and it contained small amounts of THC, though not an intoxicating amount. Oregon allows its CBD oil…
Continue reading...